Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11001
CALL
SunCoke Energy
SXC
$862M
| $102K | ﹤0.01% |
11,700
-1,300
| -10% | -$12K |
|
|
NAGE
11002
CALL
Niagen Bioscience
NAGE
$260M
| $101K | ﹤0.01% |
27,800
-46,000
| -62% | -$145K |
|
|
MAGN
11003
CALL
Magnera Corp
MAGN
$441M
| $101K | ﹤0.01% |
+4,323
| New | +$90.5K |
|
11004
Outdoor Holding Co
POWW
$253M
| $100K | ﹤0.01% |
70,190
+26,043
| +59% | +$41.3K |
|
11005
CALL
Clarivate
CLVT
$1.29B
| $100K | ﹤0.01% |
+14,100
| New | +$89.9K |
|
|
MTR
11006
Mesa Royalty Trust
MTR
$4.17M
| $100K | ﹤0.01% |
17,619
+5,701
| +48% | +$40.9K |
|
|
BHR
11007
Braemar Hotels & Resorts
BHR
$139M
| $99.7K | ﹤0.01% |
32,256
+720
| +2% | +$2.26K |
|
|
IMA
11008
ImageneBio Inc
IMA
$60.6M
| $98.8K | ﹤0.01% |
4,758
-2,177
| -31% | -$44K |
|
11009
PUT
Verastem
VSTM
$654M
| $98.7K | ﹤0.01% |
33,000
+13,600
| +70% | +$36.9K |
|
|
VTYX
11010
PUT
DELISTED
Ventyx Biosciences
VTYX
| $98.3K | ﹤0.01% |
45,100
-157,400
| -78% | -$362K |
|
11011
Newegg Commerce
NEGG
$350M
| $98.3K | ﹤0.01% |
6,649
-308
| -4% | -$5.27K |
|
11012
Genelux
GNLX
$120M
| $98.2K | ﹤0.01% |
41,432
-32,426
| -44% | -$71.4K |
|
11013
PUT
Full House Resorts
FLL
$75.5M
| $97.9K | ﹤0.01% |
19,500
-5,100
| -21% | -$26K |
|
|
CMRX
11014
DELISTED
Chimerix, Inc.
CMRX
| $97.8K | ﹤0.01% |
105,158
+10,081
| +11% | +$8.99K |
|
|
AVDX
11015
DELISTED
AvidXchange
AVDX
| $97.6K | ﹤0.01% |
12,033
-45,206
| -79% | -$426K |
|
11016
Valens Semiconductor
VLN
$195M
| $97.6K | ﹤0.01% |
44,351
+11,101
| +33% | +$26.3K |
|
11017
PUT
Cardiff Oncology
CRDF
$73.1M
| $97.5K | ﹤0.01% |
36,500
+9,700
| +36% | +$22.9K |
|
11018
VTEX
VTEX
$595M
| $97.2K | ﹤0.01% |
13,069
-57,651
| -82% | -$401K |
|
|
ZH
11019
CALL
Zhihu
ZH
$242M
| $97K | ﹤0.01% |
25,200
-142,300
| -85% | -$459K |
|
11020
PUT
Banco Santander
SAN
$213B
| $96.9K | ﹤0.01% |
19,000
-18,500
| -49% | -$88.9K |
|
11021
CALL
SkinHealth Systems
SKIN
$89.1M
| $96.6K | ﹤0.01% |
67,100
-16,900
| -20% | -$27.7K |
|
|
BGFV
11022
PUT
DELISTED
Big 5 Sporting Goods
BGFV
| $96.6K | ﹤0.01% |
46,200
+19,100
| +70% | +$40.8K |
|
11023
Microvast
MVST
$278M
| $96.4K | ﹤0.01% |
386,377
-476,967
| -55% | -$159K |
|
|
NB
11024
NioCorp Developments
NB
$601M
| $96.2K | ﹤0.01% |
44,136
+27,822
| +171% | +$51K |
|
11025
Bolt Biotherapeutics
BOLT
$7.34M
| $95.9K | ﹤0.01% |
7,396
+6,275
| +560% | +$86.5K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.